Skip to main content

  • Search
  • Contact
  • Learning Center
  • Donate
  • About
    • Acknowledgements & Partners
    • Board of Directors
    • Our Staff
  • Our Work
    • NCSD Projects
    • Partnerships & Collaborations
    • Federal & State Policy
    • Clinic+: The STD and Sexual Health Clinic Initiative
    • Disease Intervention
    • Technical Assistance
  • NCSD Connect
  • Get Involved
    • NCSD Membership
    • Job Board
    • NCSD Member Profile
    • Explore Resources
    • Share Your Story
  • Resources
  • Events
  • News & Announcements
> News & Announcements > This Week in Congress – July 30, 2021
Policy Update

This Week in Congress – July 30, 2021

Here's the scoop on what's happening this week in Congress

Author
NCSD Policy Staff
Release Date
August 2, 2021

Infrastructure

After a bipartisan deal was reached, the Senate voted on Wednesday evening (67-32) to invoke cloture on a motion to proceed on the bipartisan infrastructure package, H.R. 3684, which provides $550 billion in new spending – a decrease from the earlier $579 billion negotiated White House / Senate June proposal. While the timing on Senate action has not been set, the Senate convened on Thursday to resume consideration of a motion to proceed on the bipartisan infrastructure package and debate may continue into this weekend.

So far, the agreement includes:

  • $110 billion for roads, bridges and major projects;
  • $73 billion for electric grid upgrades;
  • $66 billion for rail and Amtrak improvements;
  • $65 billion for broadband expansion;
  • $55 billion for clean drinking water;
  • $39 billion for transit;
  • $17 billion for ports and $25 billion for airports; and
  • $7.5 billion for electric vehicle chargers.

Appropriations

On Thursday, the House finished work on its seven-bill maxibus (H.R. 4502) which will likely pass on a party-line vote

COVID Vaccinations

New data show that the efficacy of the Pfizer/BioNTech Covid-19 vaccine dropped from 96 percent to 84 percent over six months. The decline could fuel Pfizer’s case that a third booster shot may be needed eventually. The data — which were released in a preprint and not peer-reviewed — suggest that the vaccine was 91 percent effective overall at preventing Covid-19 over six months. Efficacy seemed to fall by an average of 6 percent every two months after doses were administered, the 44,000-person study found, with a peak of 96 percent efficacy within two months of vaccination. At the same time, the overall efficacy of the vaccine against severe disease, including those with low blood oxygen levels, was 97 percent.

Read this next:

Federal Policy Update – May 2, 2025

May 2, 2025

Federal Policy Update – April 18, 2025

April 18, 2025

Federal Policy Update – April 11, 2025

April 11, 2025
Become an NCSD Member! Learn more here.
  • About
    • Our Staff
    • Board of Directors
    • Acknowledgements & Partners
  • Our Work
    • Member Services
    • NCSD Projects
    • Federal & State Policy
    • Technical Assistance
    • Partnerships & Collaborations
    • DIS
    • Clinic+: The STD and Sexual Health Clinic Initiative
  • Get Involved
    • Become a Member
    • Find a Job
    • Explore Resources
    • Share Your Story
  • Resources
  • News & Announcements
  • Events
  • Learning Center
  • Get in Touch
  • Organizational Financial Statements
  • Donate
© Copyright NCSD 2025.
Privacy Policy Credits